In a strong push toward a bio-driven economic paradigm, Union Minister Jitendra Singh on Saturday championed the BioE3 policy as a cornerstone of India’s futuristic development blueprint. During his address at the BRIC-Rajiv Gandhi Centre for Biotechnology in Thiruvananthapuram, following the groundbreaking for an advanced cGMP facility, he spotlighted the policy’s role in elevating biotechnology to economic primacy.
Singh drew attention to the burgeoning scope of nuclear medicine research post-government liberalization. Calling for robust partnerships between national R&D bodies and private sectors, he stressed the Nuclear Medical Mission’s potential to drive integrated research and real-world applications.
The event saw the dedication of the National Facility for Recombinant Cells and Sensors alongside the kickoff of Science Day celebrations. Singh celebrated India’s exclusive BioE3 initiative, which fuses biotech innovations with sustainability, environmental goals, and job creation in a circular economy.
He referenced the Biopharma Shakti Mission, affirming policymakers’ recognition of the world’s accelerating bio-economy. The last ten years have witnessed unprecedented investments in science, especially biotech, yielding stellar results at institutions like BRIC-RGCB.
Here, experts have excelled in molecular biology, genomics, disease mechanisms, and oncology, drawing top talent for advanced sequencing and bioinformatics work. Dr. Rajesh Gokhale highlighted biotech’s transformative impact, with BioE3 covering bio-manufacturing among other sectors, and credited institute data for HPV vaccine drives.
Dr. T.R. Santhosh Kumar noted the facility’s repository of 600-700 stable cell lines for cancer research, positioning it globally. The new cGMP setup promises affordable therapies, broadening access to cutting-edge gene and cell treatments across India.